Technical Analysis for MGNX - MacroGenics, Inc.

Grade Last Price % Change Price Change
F 25.11 -1.26% -0.32
MGNX closed down 1.26 percent on Tuesday, July 27, 2021, on 52 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
Earnings due: Jul 28
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Flat
Historical MGNX trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
Spinning Top Other 0.00%
Fell Below 200 DMA Bearish -1.26%
Crossed Above 200 DMA Bullish -2.60%
200 DMA Resistance Bearish -0.24%
Fell Below 200 DMA Bearish -1.53%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.53%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.41%
Crossed Above 200 DMA Bullish -2.41%
Oversold Stochastic Weakness -2.41%
Older End-of-Day Signals for MGNX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Support about 13 hours ago
Down 3% about 14 hours ago
Down 2 % about 14 hours ago
Down 1% about 14 hours ago
Fell Below 10 DMA about 14 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

MacroGenics, Inc. Description

MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. The company generates its pipeline of product candidates from its proprietary suite of next-generation antibody technology platforms, which it believes improve the performance of monoclonal antibodies and antibody-derived molecules. The company creates both differentiated molecules that are directed to novel cancer targets, as well as "bio-betters," which are drugs designed to improve upon marketed medicines. The combination of MacroGenics' technology platforms and antibody engineering expertise has allowed the company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Cancer Life Sciences Biology Immunology Immune System Treatment Of Cancer Antibodies Autoimmune Diseases Monoclonal Antibody Monoclonal Antibodies Autoimmune Disease Antibody Novel Cancer

Is MGNX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 36.4804
52 Week Low 18.16
Average Volume 775,052
200-Day Moving Average 25.59
50-Day Moving Average 26.40
20-Day Moving Average 26.23
10-Day Moving Average 25.13
Average True Range 1.26
ADX 17.49
+DI 16.80
-DI 23.51
Chandelier Exit (Long, 3 ATRs) 25.39
Chandelier Exit (Short, 3 ATRs) 27.72
Upper Bollinger Bands 29.00
Lower Bollinger Band 23.47
Percent B (%b) 0.3
BandWidth 21.08
MACD Line -0.29
MACD Signal Line -0.27
MACD Histogram -0.0275
Fundamentals Value
Market Cap 1.41 Billion
Num Shares 56.2 Million
EPS -3.47
Price-to-Earnings (P/E) Ratio -7.23
Price-to-Sales 14.78
Price-to-Book 4.35
PEG Ratio 0.01
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 27.23
Resistance 3 (R3) 27.28 26.63 26.87
Resistance 2 (R2) 26.63 26.09 26.60 26.75
Resistance 1 (R1) 25.87 25.76 25.55 25.82 26.64
Pivot Point 25.22 25.22 25.06 25.19 25.22
Support 1 (S1) 24.46 24.68 24.14 24.41 23.58
Support 2 (S2) 23.81 24.35 23.78 23.47
Support 3 (S3) 23.05 23.81 23.35
Support 4 (S4) 23.00